World's Best Scientists 2026 revealed!
Olivier Boyer

Olivier Boyer

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 55 3813 3515 176 159 222 10152

Olivier Boyer publications per year

The chart shows the history of publications by Olivier Boyer between 1996 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Olivier Boyer published across 30 years, from 1996 to 2025, averaging 9.7 papers a year. Output peaked at 25 publications in 2025. 36 of the 290 publications appeared in the last two years.

No. of publications
5 10 15 20 25
Bar chart. Horizontal axis: year, 1996 to 2025. Vertical axis: number of publications, 0 to 25. Peak 25 publications in 2025. 1996: 1 publication 1997: 2 publications 1998: 5 publications 1999: 2 publications 2000: 4 publications 2001: 2 publications 2002: 3 publications 2003: 5 publications 2004: 10 publications 2005: 2 publications 2006: 9 publications 2007: 0 publications 2008: 3 publications 2009: 9 publications 2010: 10 publications 2011: 11 publications 2012: 18 publications 2013: 15 publications 2014: 13 publications 2015: 15 publications 2016: 18 publications 2017: 13 publications 2018: 8 publications 2019: 13 publications 2020: 16 publications 2021: 20 publications 2022: 10 publications 2023: 17 publications 2024: 11 publications 2025: 25 publications
1996 2025

290 publications in total across all disciplines

View publications per year as a table
Olivier Boyer: publications per year, 1996 to 2025
Year Publications
1996 1
1997 2
1998 5
1999 2
2000 4
2001 2
2002 3
2003 5
2004 10
2005 2
2006 9
2007 0
2008 3
2009 9
2010 10
2011 11
2012 18
2013 15
2014 13
2015 15
2016 18
2017 13
2018 8
2019 13
2020 16
2021 20
2022 10
2023 17
2024 11
2025 25
Total 290
Download as CSV

Olivier Boyer publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Olivier Boyer sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 222–231 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 222 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168 222
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Olivier Boyer D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Olivier Boyer sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 54–55 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 55 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155 55
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Olivier Boyer is affiliated with the University of Rouen in France and has contributed extensively to the field of medicine, with a particular focus on rheumatology, pathology and forensic medicine, epidemiology, immunology, and molecular biology. Their research spans a range of interdisciplinary areas within medical science.

The scientist's recent scholarly output includes notable papers such as:

  • Immune-mediated necrotizing myopathy: clinical features and pathogenesis (2020, Nature Reviews Rheumatology)
  • Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients (2021, Journal of the American Society of Nephrology)
  • CD11c+ B Cells Are Mainly Memory Cells, Precursors of Antibody Secreting Cells in Healthy Donors (2020, Frontiers in Immunology)
  • Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients (2021, Kidney International)
  • Pyroptotic and Necroptotic Cell Death in the Tumor Microenvironment and Their Potential to Stimulate Anti-Tumor Immune Responses (2021, Frontiers in Oncology)

The research topics addressed by Olivier Boyer emphasize inflammatory myopathies and dermatomyositis, autoimmune bullous skin diseases, CAR-T cell therapy research, platelet disorders and treatments, coagulation and related biochemical pathways, monoclonal and polyclonal antibody research, as well as muscle physiology and disorders.

Frequent coauthors collaborating on these studies include:

  • J. Martinet
  • Marie-Laure Golinski
  • Sébastien Calbo
  • Maud Maho-Vaillant
  • V. Hébert

The scientist regularly publishes in journals such as Frontiers in Immunology, Lara D. Veeken, Annales de Dermatologie et de Vénéréologie, Annales de Dermatologie et de Vénéréologie - FMC, and Bone Marrow Transplantation, indicating a sustained involvement in specialized medical research communities.

Olivier Boyer's research contributes broadly to understanding complex immune-mediated diseases and therapeutic responses, aligning with emerging challenges in medicine such as vaccine efficacy and tumor immunology.

Best Publications

  • Single domain antibodies: promising experimental and therapeutic tools in infection and immunity.

    Janusz Wesolowski;Vanina Alzogaray;Jan Reyelt;Mandy Unger

  • A Phase I/II Study of Herpes Simplex Virus Type 1 Thymidine Kinase "Suicide" Gene Therapy for Recurrent Glioblastoma

    David Klatzmann;Charles A. Valéry;Gilbert Bensimon;Beatrice Marro

  • Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin.

    Yves Allenbach;Laurent Drouot;Aude Rigolet;Jean Luc Charuel

  • CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis.

    Olivier Boyer;David Saadoun;Julien Abriol;Mélanie Dodille

  • Immune-mediated necrotizing myopathy: clinical features and pathogenesis.

    Yves Allenbach;Olivier Benveniste;Werner Stenzel;Olivier Boyer

  • High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.

    Yves Allenbach;Jeremy Keraen;Anne-Marie Bouvier;Valérie Jooste

  • The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation.

    Alexa S. Green;Alexa S. Green;Nicolas Chapuis;Nicolas Chapuis;Thiago Trovati Maciel;Lise Willems;Lise Willems

  • Correlation of anti–signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy

    Olivier Benveniste;Laurent Drouot;Fabienne Jouen;Jean-Luc Charuel

  • Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2–P2X7 pathway

    Sandra Hubert;Björn Rissiek;Katjana Klages;Jochen Huehn

  • Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients.

    Dominique Bertrand;Mouad Hamzaoui;Veronique Lemée;Julie Lamulle

  • Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction.

    Zachary Fitzpatrick;Christian Leborgne;Elena Barbon;Elisa Masat

  • Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation.

    Aude Marie-Cardine;Florence Divay;Ingrid Dutot;Alexa Green

  • Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies.

    Louiza Arouche-Delaperche;Yves Allenbach;Damien Amelin;Corinna Preusse

  • Necrosis in anti-SRP+ and anti-HMGCR+myopathies: Role of autoantibodies and complement.

    Yves Allenbach;Louiza Arouche-Delaperche;Corinna Preusse;Helena Radbruch

  • In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy.

    Cécile Bergua;Hélène Chiavelli;Yves Allenbach;Louiza Arouche-Delaperche

  • Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken

    Olivier Benveniste;Werner Stenzel;David Hilton-Jones;Marco Sandri

  • Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study

    Lucile Musset;Yves Allenbach;Olivier Benveniste;Olivier Boyer

  • CD11c+ B Cells Are Mainly Memory Cells, Precursors of Antibody Secreting Cells in Healthy Donors.

    Marie-Laure Golinski;Mélanie Demeules;Céline Derambure;Gaetan Riou

  • A Phase I/II Dose-Escalation Study of Herpes Simplex Virus Type 1 Thymidine Kinase "Suicide" Gene Therapy for Metastatic Melanoma

    David Klatzmann;Patrick Chérin;Gilbert Bensimon;Olivier Boyer

  • Prevention of Graft-Versus-Host Disease in Mice Using a Suicide Gene Expressed in T Lymphocytes

    José L. Cohen;Olivier Boyer;Benoı̂t Salomon;Rosine Onclercq

  • Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP).

    Jean-Benoit Arlet;Dalia Dimitri;Christian Pagnoux;Olivier Boyer

Frequent Co-Authors

Olivier Benveniste
Olivier Benveniste Sorbonne University
David Klatzmann
David Klatzmann Sorbonne University
Pascal Joly
Pascal Joly University of Rouen
Lucile Musset
Lucile Musset Sorbonne University
François Tron
François Tron University of Rouen
Bruno Eymard
Bruno Eymard Université Paris Cité
Friedrich Koch-Nolte
Friedrich Koch-Nolte Universität Hamburg
Friedrich Haag
Friedrich Haag Universität Hamburg
Federico Mingozzi
Federico Mingozzi University of Pennsylvania
Patrice Cacoub
Patrice Cacoub Sorbonne University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, pursuing related online degrees can open new career doors in healthcare. Nursing, especially specialized roles like Psychiatric-Mental Health Nurse Practitioner, offers affordable pathways with programs such as affordable pmhnp programs that blend convenience with quality education.

Understanding compensation trends is crucial when selecting a career path. The dnp salary transparency resource provides valuable insights into Doctor of Nursing Practice earnings across different states, helping candidates make informed decisions about their future.

For nurse practitioners aiming to specialize further, transitioning roles is common. Resources covering the fnp to acute care certification guide help nurses smoothly shift from Family Nurse Practitioner to Acute Care NP, expanding their clinical scope and career options.

Additionally, accelerated programs enable quicker entry into advanced nursing roles. The accelerated np programs listed provide fast-tracked educational routes for motivated professionals ready to advance.

Best Scientists Citing Olivier Boyer

Trending Scientists

Recently Published Articles